FDA grants speedy expanded approval for Seattle Genetics\' Adcetris in firstline peripheral Tcell lymphoma httpswww.firstwordpharma.comnode1605118tsid28®ionid6Â

FDA grants speedy expanded approval for Seattle Genetics' Adcetris in first-line peripheral T-cell lymphoma https://www.firstwordpharma.com/node/1605118?tsid=28®ion_id=6 …

15:06 EST 16 Nov 2018 | FirstWord Pharma

FDA grants speedy expanded approval for Seattle Genetics' Adcetris in first-line peripheral T-cell lymphoma https://www.firstwordpharma.com/node/1605118?tsid=28&region_id=6 …

More From BioPortfolio on "FDA grants speedy expanded approval for Seattle Genetics' Adcetris in first-line peripheral T-cell lymphoma https://www.firstwordpharma.com/node/1605118?tsid=28®ion_id=6 …"